1.The clinical study of the tuberculous spondylitis.
Byung Jik KIM ; han Suk KO ; Young LIM ; Jung Gook SEO ; Suk Kyu ZOO ; Tae Hwan JEON
The Journal of the Korean Orthopaedic Association 1993;28(6):2221-2232
No abstract available.
Spondylitis*
2.Hair Growth Promoting Potential of Phospholipids Purified from Porcine Lung Tissues.
Seong Hyun CHOI ; Jeong Su MOON ; Byung Suk JEON ; Yeon Jeong JEON ; Byung Il YOON ; Chang Jin LIM
Biomolecules & Therapeutics 2015;23(2):174-179
BP201, porcine lung tissue-derived phospholipids, consists of phosphatidylcholine as a major phospholipid species. BP201 promoted hair growth after application onto the shaved backs of BALB/c and C3H mice. Its effect was enhanced when applied together with minoxidil (MNX) in C3H mice. When the tissue specimens prepared from the shaved skins of BP201-treated and control mice were microscopically examined, the total numbers of hair follicles in both anagen and telogen phases of BP201-treated mice were significantly higher than those of control mice. The numbers of hair follicles in the anagen phase of BP201-treated mice were also higher than those of control mice. In combination with MNX, BP201 further increased the total number of hair follicles, but did not alter the percentage of hair follicles in the anagenic phase. BP201 also increased the proliferation of human hair follicle dermal papilla cells. Collectively, BP201 possesses hair growth promoting potential, which would suggest its use singly or in combination for hair growth products.
Animals
;
Hair Follicle
;
Hair*
;
Humans
;
Lung*
;
Mice
;
Mice, Inbred C3H
;
Minoxidil
;
Phosphatidylcholines
;
Phospholipids*
;
Skin
3.Embryonal rhabdomyosarcoma in the abdominal cavity of an aged Sprague-Dawley rat.
Hak Soo KIM ; Byung Suk JEON ; Byung Woo LEE ; Byung Il YOON
Korean Journal of Veterinary Research 2015;55(1):71-73
We report a spontaneous embryonal rhabdomyosarcoma in the abdominal cavity of an aged (88-week-old) Sprague-Dawley rat. The animal had a firm lobulated 5 x 5 x 4.5 cm mass in the abdominal cavity that was whitish to tan with necrotic and hemorrhagic plaques. Microscopically, the mass contained nodules with spindle or globoid shaped neoplastic cells with abundant eosinophilic cytoplasm and round or elongated nuclei mixed with other spindle cells with a filamentous appearance and scanty cytoplasm. Multinucleated cells and cross-striations were also observed. The neoplastic cells were positive for vimentin, desmin, and alpha-smooth muscle actin, especially the small spindle cells.
Abdominal Cavity*
;
Actins
;
Animals
;
Cytoplasm
;
Desmin
;
Eosinophils
;
Rats*
;
Rats, Sprague-Dawley*
;
Rhabdomyosarcoma, Embryonal*
;
Triacetoneamine-N-Oxyl
;
Vimentin
4.Uterine leiomyosarcoma in a wild rat (Rattus norvegicus): usefulness of Ki-67 labeling index for diagnosis.
Byung Suk JEON ; Hyung Gi KIM ; Byung Woo LEE ; Jeong Hee HAN ; Byung Il YOON
Laboratory Animal Research 2013;29(2):127-130
Uterine smooth muscle tumor is very rare in laboratory rats and, there has been no report in the wild rodents. Among a total of 400 wild rats captured in Gyeonggi, Gangwon, and Chungbuk provinces of Korea in 2007, 2010, and 2011, we found a uterine spindle cell tumor, diagnosed as smooth muscle cell origin based on differential features of histology and immunohistochemistry. Its incidence was very low, like in the laboratory rats, as under 0.5% for female. Considering generally applied histological and cellular criteria, this case was difficult in differential diagnosis between benign and malignant. Ki-67 labeling index was therefore further investigated, and it ranged from 26.4 to 37.6% in the 10 different areas, representing an average of 32.9+/-0.05%. The Ki-67 labeling index of neoplastic cells near the necrotic area was recorded as 83.5%. According to such high Ki-67 labeling index, it was more likely a malignant leiomyosarcoma, assenting to the previous proposal that Ki-67 labeling index is a significant criterion to differentiate between malignant and benign in the smooth muscle tumors.
Animals
;
Diagnosis, Differential
;
Female
;
Humans
;
Immunohistochemistry
;
Incidence
;
Korea
;
Leiomyosarcoma
;
Myocytes, Smooth Muscle
;
Rats
;
Rodentia
;
Smooth Muscle Tumor
5.Development of resistance to reinfection by Clonorchis sinensis in rats.
Byung Suk CHUNG ; Hongman ZHANG ; Min Ho CHOI ; Deogkyu JEON ; Shunyu LI ; Mejeong LEE ; Sung Tae HONG
The Korean Journal of Parasitology 2004;42(1):19-26
We investigated the induction of resistance to Clonorchis sinensis infection by prior infection in rat and hamster models. Animals were challenged with C. sinensis metacercariae, then treated with praziquantel and reinfected. Worm recovery rate in reinfected animals was used to estimate resistance to reinfection. The determined resistance rates to reinfection in rats and hamsters were 97.7% and 10.3%, respectively. In rats, cure from the primary infection of C. sinensis increased resistant to reinfection, and the greatert the worm burden and the longer the duration of primary infection, the higher was the resistance rate. For primary infection doses of 10, 40 and 100 metacercariae per rat, the resistance rates were 87.4%, 93.8% and 98.4%, respectively. The resistance rates in rats after 2 or 8-week primary infection were 78.7% and 95.3%, respectively. All worms recovered from reinfected rats were immature. When cured rats were administered with methylprednisolone, resistance to reinfection became impaired. These findings indicate that rats develop a high degree of resistance to reinfection by C. sinensis after cure. The growths and maturations of reinfected worms were also impaired.
Animals
;
Anthelmintics/administration & dosage/therapeutic use
;
Anti-Inflammatory Agents/administration & dosage
;
Clonorchiasis/*immunology/parasitology/*pathology
;
Clonorchis sinensis/*pathogenicity
;
Disease Models, Animal
;
Female
;
Hamsters
;
Immunocompetence
;
Immunosuppression
;
Male
;
Mesocricetus
;
Methylprednisolone/administration & dosage
;
Praziquantel/administration & dosage/therapeutic use
;
Rats
;
Rats, Sprague-Dawley
;
Support, Non-U.S. Gov't
6.Hypothalamic Ganglioglioma: Case Report.
Yong Woon CHO ; Jae Gon MOON ; In Suk PARK ; Byung Chan JEON ; Han Kyu KIM ; Hee Kyung CHANG
Journal of Korean Neurosurgical Society 2000;29(5):688-692
No abstract available.
Ganglioglioma*
7.Non-Watertight Intermittent Dural Closure in Neurological Surgery.
Yong Woon CHO ; Jae Gon MOON ; Yong Soon HWANG ; In Suk PARK ; Byung Chan JEON ; Han Kyu KIM
Journal of Korean Neurosurgical Society 2000;29(5):640-643
No abstract available.
8.International regulatory considerations pertaining to the development of stem cell-based veterinary medicinal products
Byung-Suk JEON ; Hee YI ; Hyun-Ok KU
Journal of Veterinary Science 2021;22(1):e6-
Stem cell-based products (SCPs) are an emerging field of veterinary medicine that focuses on the regeneration, repair, or replacement of damaged tissues or organs. However, there are some issues in applying the traditional regulatory guideline for the approval of SCPs as veterinary medicinal products. This article describes the positions of Korea, US, and EU regarding SCPs, and compares the regulatory guidelines of each country for their safety evaluation. Although there are some differences in the regulatory guidelines, similar considerations in identifying the quality of SCPs and their safety has adopted. Overall, these guidelines need to be harmonized among countries.
9.Usefulness of Prostate-Specific Antigen Density as an Indicator for Recommending Prebiopsy Magnetic Resonance Imaging to Prevent Missed Prostate Cancer Diagnoses
Jin Hyung JEON ; Kyo Chul KOO ; Byung Ha CHUNG ; Kwang Suk LEE
Korean Journal of Urological Oncology 2021;19(3):155-163
Purpose:
To identify the indication for recommending prebiopsy magnetic resonance imaging (MRI) to prevent prostate cancer missed diagnoses in cases without prebiopsy MRI.
Materials and Methods:
Between January 2017 and September 2020, 585 patients suspected with prostate cancer underwent prostate biopsy after MRI. For patients with visible lesions, MRI-targeted biopsy using an image-based fusion program was performed in addition to the 12- core systematic biopsy. Patients for whom MRI was performed in other institutions (n=4) and patients who underwent target biopsy alone (n=7) were excluded.
Results:
Of 574 patients (median prostate-specific antigen [PSA] level, 6.88 ng/mL; mean age, 68.2 years), 342 (59.6%) were diagnosed with prostate cancer (visible lesions=312/449 [69.5%]; nonvisible lesions=30/123 [24.0%]). The detection rates of visible lesions stratified using the Prostate Imaging Reporting and Data System score (3 vs. 4 vs. 5) were 30.9% (54 of 175), 61.2% (150 of 245), and 90.1% (127 of 141), respectively. Multivariate analysis showed that PSA density was a significant factor for presence of visible lesions, prostate cancer, and significant prostate cancer diagnosis. Among patients with positive lesions, 27 (8.2%) were diagnosed with prostate cancer concomitant with negative systematic biopsy results. A PSA density of 0.15 ng/mL/cm3 was identified as the significant cutoff value for predicting positive target biopsy in groups with negative systematic biopsy. Sixty of the negative target lesions (26.1%) were diagnosed using systematic biopsy.
Conclusions
To maximize cancer detection rates, both targeted and systematic biopsies should be implemented. PSA density was identified as a useful factor for recommending prebiopsy MRI to patients suspected with prostate cancer.
10.Usefulness of Prostate-Specific Antigen Density as an Indicator for Recommending Prebiopsy Magnetic Resonance Imaging to Prevent Missed Prostate Cancer Diagnoses
Jin Hyung JEON ; Kyo Chul KOO ; Byung Ha CHUNG ; Kwang Suk LEE
Korean Journal of Urological Oncology 2021;19(3):155-163
Purpose:
To identify the indication for recommending prebiopsy magnetic resonance imaging (MRI) to prevent prostate cancer missed diagnoses in cases without prebiopsy MRI.
Materials and Methods:
Between January 2017 and September 2020, 585 patients suspected with prostate cancer underwent prostate biopsy after MRI. For patients with visible lesions, MRI-targeted biopsy using an image-based fusion program was performed in addition to the 12- core systematic biopsy. Patients for whom MRI was performed in other institutions (n=4) and patients who underwent target biopsy alone (n=7) were excluded.
Results:
Of 574 patients (median prostate-specific antigen [PSA] level, 6.88 ng/mL; mean age, 68.2 years), 342 (59.6%) were diagnosed with prostate cancer (visible lesions=312/449 [69.5%]; nonvisible lesions=30/123 [24.0%]). The detection rates of visible lesions stratified using the Prostate Imaging Reporting and Data System score (3 vs. 4 vs. 5) were 30.9% (54 of 175), 61.2% (150 of 245), and 90.1% (127 of 141), respectively. Multivariate analysis showed that PSA density was a significant factor for presence of visible lesions, prostate cancer, and significant prostate cancer diagnosis. Among patients with positive lesions, 27 (8.2%) were diagnosed with prostate cancer concomitant with negative systematic biopsy results. A PSA density of 0.15 ng/mL/cm3 was identified as the significant cutoff value for predicting positive target biopsy in groups with negative systematic biopsy. Sixty of the negative target lesions (26.1%) were diagnosed using systematic biopsy.
Conclusions
To maximize cancer detection rates, both targeted and systematic biopsies should be implemented. PSA density was identified as a useful factor for recommending prebiopsy MRI to patients suspected with prostate cancer.